Boston Scientific Corporation (0HOY.L)
USD 105.22
(1.9%)
USD 105.22
(1.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.24 Billion USD | 12.29% |
| 2022 | 12.68 Billion USD | 6.68% |
| 2021 | 11.88 Billion USD | 19.92% |
| 2020 | 9.91 Billion USD | -7.66% |
| 2019 | 10.73 Billion USD | 9.28% |
| 2018 | 9.82 Billion USD | 8.57% |
| 2017 | 9.04 Billion USD | 7.89% |
| 2016 | 8.38 Billion USD | 12.16% |
| 2015 | 7.47 Billion USD | 2.31% |
| 2014 | 7.3 Billion USD | 3.37% |
| 2013 | 7.07 Billion USD | -2.47% |
| 2012 | 7.24 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.85 Billion USD | 3.52% |
| 2024 Q2 | 4.12 Billion USD | 6.85% |
| 2024 Q3 | 4.2 Billion USD | 2.16% |
| 2023 Q3 | 3.52 Billion USD | -2.0% |
| 2023 Q4 | 3.72 Billion USD | 5.61% |
| 2023 Q1 | 3.38 Billion USD | 4.53% |
| 2023 Q2 | 3.59 Billion USD | 6.2% |
| 2023 FY | 14.24 Billion USD | 12.29% |
| 2022 Q4 | 3.24 Billion USD | 2.27% |
| 2022 Q2 | 3.24 Billion USD | 7.2% |
| 2022 Q1 | 3.02 Billion USD | -3.23% |
| 2022 FY | 12.68 Billion USD | 6.68% |
| 2022 Q3 | 3.17 Billion USD | -2.28% |
| 2021 Q3 | 2.93 Billion USD | -4.71% |
| 2021 FY | 11.88 Billion USD | 19.92% |
| 2021 Q1 | 2.75 Billion USD | 1.59% |
| 2021 Q2 | 3.07 Billion USD | 11.81% |
| 2021 Q4 | 3.12 Billion USD | 6.65% |
| 2020 Q3 | 2.65 Billion USD | 32.75% |
| 2020 Q4 | 2.7 Billion USD | 1.88% |
| 2020 FY | 9.91 Billion USD | -7.66% |
| 2020 Q1 | 2.54 Billion USD | -12.43% |
| 2020 Q2 | 2 Billion USD | -21.23% |
| 2019 Q3 | 2.7 Billion USD | 2.89% |
| 2019 Q2 | 2.63 Billion USD | 5.54% |
| 2019 FY | 10.73 Billion USD | 9.28% |
| 2019 Q1 | 2.49 Billion USD | -2.66% |
| 2019 Q4 | 2.9 Billion USD | 7.28% |
| 2018 Q3 | 2.39 Billion USD | -3.9% |
| 2018 Q1 | 2.37 Billion USD | -1.2% |
| 2018 Q2 | 2.49 Billion USD | 4.67% |
| 2018 Q4 | 2.56 Billion USD | 7.02% |
| 2018 FY | 9.82 Billion USD | 8.57% |
| 2017 Q1 | 2.16 Billion USD | -1.41% |
| 2017 FY | 9.04 Billion USD | 7.89% |
| 2017 Q4 | 2.4 Billion USD | 8.37% |
| 2017 Q3 | 2.22 Billion USD | -1.55% |
| 2017 Q2 | 2.25 Billion USD | 4.49% |
| 2016 FY | 8.38 Billion USD | 12.16% |
| 2016 Q1 | 1.96 Billion USD | 3.37% |
| 2016 Q2 | 2.12 Billion USD | 8.25% |
| 2016 Q3 | 2.1 Billion USD | -0.99% |
| 2016 Q4 | 2.19 Billion USD | 4.09% |
| 2015 Q4 | 1.9 Billion USD | 0.64% |
| 2015 Q3 | 1.88 Billion USD | 2.44% |
| 2015 FY | 7.47 Billion USD | 2.31% |
| 2015 Q2 | 1.84 Billion USD | 4.24% |
| 2015 Q1 | 1.76 Billion USD | -2.59% |
| 2014 FY | 7.3 Billion USD | 3.37% |
| 2014 Q2 | 1.87 Billion USD | 5.58% |
| 2014 Q4 | 1.81 Billion USD | -1.68% |
| 2014 Q3 | 1.84 Billion USD | -1.44% |
| 2014 Q1 | 1.77 Billion USD | 0.51% |
| 2013 Q1 | 1.76 Billion USD | -3.29% |
| 2013 Q3 | 1.73 Billion USD | -4.09% |
| 2013 Q4 | 1.76 Billion USD | 1.73% |
| 2013 FY | 7.07 Billion USD | -2.47% |
| 2013 Q2 | 1.8 Billion USD | 2.73% |
| 2012 Q4 | 1.82 Billion USD | 0.0% |
| 2012 FY | 7.24 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -3896.643% |
| Accuray Incorporated | 446.55 Million USD | -3088.885% |
| Align Technology, Inc. | 3.86 Billion USD | -268.696% |
| Elevance Health Inc. | 171.34 Billion USD | 91.689% |
| AxoGen, Inc. | 159.01 Million USD | -8855.299% |
| CVS Health Corporation | 357.77 Billion USD | 96.02% |
| Cardinal Health, Inc. | 226.82 Billion USD | 93.722% |
| Centene Corporation | 141.26 Billion USD | 89.92% |
| DaVita Inc. | 12.14 Billion USD | -17.297% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 78.082% |
| Hologic, Inc. | 4.03 Billion USD | -253.324% |
| Humana Inc. | 106.37 Billion USD | 86.613% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -288.97% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -17.09% |
| Masimo Corporation | 2.04 Billion USD | -595.279% |
| McKesson Corporation | 308.95 Billion USD | 95.391% |
| Patterson Companies, Inc. | 6.56 Billion USD | -116.8% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -53.913% |
| ResMed Inc. | 4.68 Billion USD | -203.93% |
| Henry Schein, Inc. | 12.33 Billion USD | -15.406% |
| Teladoc Health, Inc. | 2.6 Billion USD | -447.184% |
| Universal Health Services, Inc. | 14.28 Billion USD | 0.294% |
| Veeva Systems Inc. | 2.36 Billion USD | -502.452% |
| Baxter International Inc. | 14.81 Billion USD | 3.868% |
| Becton, Dickinson and Company | 19.37 Billion USD | 26.492% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -99.885% |
| Danaher Corporation | 23.89 Billion USD | 40.393% |
| Stryker Corporation | 20.49 Billion USD | 30.53% |
| Medtronic plc | 32.36 Billion USD | 56.0% |